تقرير
Case Report: Chronic Cavitatory Pulmonary Aspergillosis after COVID-19.
| العنوان: | Case Report: Chronic Cavitatory Pulmonary Aspergillosis after COVID-19. |
|---|---|
| المؤلفون: | Chaurasia S; Department of Pulmonary Medicine, Manipal Hospital Whitefield, Bangalore, India., Thimmappa M; Department of Critical Care Medicine, Manipal Hospital Whitefield, Bangalore, India., Chowdhury S; Department of Pulmonary Medicine, Manipal Hospital Whitefield, Bangalore, India. |
| المصدر: | The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2021 Nov 24; Vol. 106 (1), pp. 105-107. Date of Electronic Publication: 2021 Nov 24. |
| نوع المنشور: | Case Reports |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Northbrook, IL : American Society of Tropical Medicine and Hygiene Original Publication: Baltimore. |
| مواضيع طبية MeSH: | COVID-19/*complications , Pulmonary Aspergillosis/*etiology, Chronic Disease ; Humans ; Male ; Middle Aged ; Pulmonary Aspergillosis/diagnostic imaging ; Tomography, X-Ray Computed |
| مستخلص: | Chronic pulmonary aspergillosis can present in four distinct clinical syndromes, one of which is chronic cavitary pulmonary aspergillosis (CCPA). CCPA is generally associated with a mildly immunosuppressed state or, in immunocompetent patients, with structural lung damage. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with reactivation of previous quiescent infections such as tuberculosis and invasive fungal infections, but CCPA in a patient with COVID-19 is rarely reported. Here we present the case of a 57-year-old man with CCPA associated with COVID-19 infection in whom latent aspergilloma was most likely activated after SARS-CoV-2 infection. The patient presented with severe COVID and, after initial response to treatment, started to deteriorate due to reactivation of latent aspergilloma to a more aggressive CCPA form. After confirmation of the diagnosis, the patient was initiated on treatment with voriconazole. He showed a good response to treatment with clinicoradiological response. This case also depicts one of the common causes of clinical deterioration in otherwise recovering COVID-19 patients. |
| References: | J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620966475. (PMID: 33054445) Med Mycol. 2017 Jan 1;55(1):48-55. (PMID: 27816904) Clin Microbiol Infect. 2020 Aug;26(8):1091.e1-1091.e7. (PMID: 31901491) Int J Surg Case Rep. 2021 May;82:105865. (PMID: 33842198) Am J Case Rep. 2019 Aug 18;20:1220-1224. (PMID: 31422416) Clin Infect Dis. 2021 Oct 5;73(7):e1645-e1648. (PMID: 32887998) Clin Microbiol Infect. 2021 Sep;27(9):1230-1241. (PMID: 33601011) Eur Respir J. 2016 Jan;47(1):45-68. (PMID: 26699723) |
| تواريخ الأحداث: | Date Created: 20211124 Date Completed: 20220117 Latest Revision: 20220803 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8733549 |
| DOI: | 10.4269/ajtmh.21-0701 |
| PMID: | 34818624 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1476-1645 |
|---|---|
| DOI: | 10.4269/ajtmh.21-0701 |